SCHEMBL7359674

SCHEMBL7359674

CCOC(=O)CN1CCCC(C(c2ccccc2)c2ccccc2)C1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
KDM4E B2RXH2 1/20 0.55
CYP3A4 P08684 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
HPGD P15428 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 1/20 0.48
TSHR P16473 1/20 0.48
RAB9A P51151 1/20 0.48
NPY2R P49146 1/20 0.45
BACE1 P56817 1/20 0.45
KMT2A Q03164 1/20 0.45
POLB P06746 1/20 0.44
GABRA5 P31644 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPK1 P28482 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3658957 0.91 ALDH1A1 (0.47) ALDH1A1KDM4ECYP3A4CYP1A2CYP2D6
SCHEMBL14282927 0.86 BACE1 (0.52) ALDH1A1KDM4EHPGDSMN1; SMN2NPC1
SCHEMBL3661510 0.83 BACE1 (0.48) ALDH1A1KDM4ECYP3A4CYP1A2CYP2D6
SCHEMBL3664387 0.78 BACE1 (0.53) KDM4ECYP3A4CYP1A2CYP2D6TSHR
SCHEMBL3661796 0.77 BACE1 (0.44) NPY2RBACE1
SCHEMBL3664705 0.77 CCR5 (0.46) ALDH1A1KDM4ECYP2D6NPY2RBACE1
SCHEMBL14282940 0.77 ALDH1A1 (0.52) ALDH1A1KDM4ENPY2RKMT2AL3MBTL1
SCHEMBL3658857 0.74 TACR1 (0.43) BACE1KMT2APOLB
SCHEMBL14198379 0.74 TSHR (0.63) ALDH1A1KDM4ETSHRNPY2RKMT2A
SCHEMBL3661405 0.74 SLC6A9 (0.52) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0918767-A4 PHARMACEUTICAL FOR TREATING OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS ALLELIX NEUROSCIENCE INC (US) 2000-04-26 EP disclosed
US-6001854-A CYCLIC AMINES FOR INHIBITING GLYCINE TRANSPORT VIA GLYCINET-1 OR GLYCINET-2 TRANSPORTER; USEFUL FOR TREATING PSYCHOLOGICAL AND OTHER BRAIN DISORDERS ALLELIX NEUROSCIENCE INC. (US) 1999-12-14 US disclosed
EP-0918767-A1 PHARMACEUTICAL FOR TREATING OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS Trophix Neuroscience Inc. (US) 1999-06-02 EP disclosed
WO-1997045423-A1 PHARMACEUTICAL FOR TREATING OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS TROPHIX NEUROSCIENCE INC. (US) 1997-12-04 WO disclosed